F. Nachit-Ouinekh
GlaxoSmithKline
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by F. Nachit-Ouinekh.
Headache | 2008
Françoise Radat; Christelle Créac'h; Evelyne Guegan-Massardier; Gérard Mick; Nathalie Guy; Nelly Fabre; Pierric Giraud; F. Nachit-Ouinekh; Michel Lanteri-Minet
Objective.— The aim of this study was to assess behavioral dependence on migraine abortive drugs in medication‐overuse headache (MOH) patients and identify the predisposing factors.
European Journal of Neurology | 2005
F. Nachit-Ouinekh; Jean-François Dartigues; Patrick Henry; J.-P. Becg; G. Chastan; N. Lemaire; A. El Hasnaoui
To assess the global impact of episodic headaches in patients consulting general practitioners (GPs) using the Headache Impact Test (HIT‐6) questionnaire, and to compare this with measures of headache severity and quality of life. A total of 2802 patients consulting 349 GPs participated to this cross‐sectional study. Data were collected on headache severity using the Migraine Severity (MIGSEV) scale, headache impact with the HIT‐6 and quality of life with the Qualité de Vie et Migraine (QVM) questionnaire. Diagnosis was assigned retrospectively according to the International Headache Society criteria. The association between the HIT‐6 scale and the other scales was determined from a Pearsons chi‐square test, an analysis of variance and Spearman correlation coefficients. Patients (2537) provided exploitable data. Six percent of the sample had little impact, 14% moderate, 14% substantial and 66% severe impact. The HIT‐6 scores were significantly different between diagnostic groups, being highest in the migraine group. The HIT‐6 score were well correlated with headache severity and QVM score. The HIT‐6 scale correlates, across different diagnostic groups of headache, with both headache severity and with quality of life.
Cephalalgia | 2009
Françoise Radat; Michel Lanteri-Minet; F. Nachit-Ouinekh; Hélène Massiou; Christian Lucas; André Pradalier; F Mercier; A. El Hasnaoui
The objective of this analysis was to describe psychological and cognitive variables in subjects with migraine and to identify those associated with chronicity. Data were collected from 10 000 subjects during face-to-face interview. Subjects with episodic migraine (n = 1127) or chronic daily headache (n = 407) with migrainous features were identified using an algorithm based on the International Classification of Headache Disorders, 2nd edn classification. Data on headache impact was obtained with the Headache Impact Test-6, on psychological distress with the Hospital Anxiety and Depression Scale, on coping with the Coping Strategy Questionnaire catastrophizing score and the Brief COPE inventory, on illness perception with the Brief Illness Perception Questionnaire and on locus of control. Psychological variables associated with chronicity include perceived headache impact, psychological distress, the use of catastrophizing and avoidance coping strategies and an externalized locus of control. In conclusion, maladaptive coping strategies should be taken into account in the management of patients with migraine. Longitudinal studies will be necessary to address the causality of the relationship observed.
Headache | 2003
Abdelkader El Hasnaoui; Muriel Vray; Alain Richard; F. Nachit-Ouinekh; François Boureau
Objectives.—To identify items that serve to assess the severity of migraine with a high level of clinical and psychometric relevance and to combine these into a unitary severity scale.
Cephalalgia | 2005
F. Nachit-Ouinekh; Virginie Chrysostome; Patrick Henry; Christophe Sourgen; Jean-François Dartigues; A. El Hasnaoui
Assignment of a diagnosis of migraine has been formalized in diagnostic criteria proposed by the International Headache Society. The objective of the present study is to determine the reproductibility of the formal diagnosis of migraine in a cohort of headache sufferers over a one-year period. The study was performed in a community cohort taking part in a long-term prospective health survey, the GAZEL study. Two thousand five hundred individuals reporting headache in the GAZEL cohort were sent two postal questionnaires concerning headache symptoms and features at 12-monthly intervals. Replies to the questions allowed a migraine diagnosis to be attributed retrospectively using an algorithm based on the IHS classification scheme. The response rate was 82% for the first questionnaire and 69% for both questionnaires. Of the 1733 subjects providing information at both time-points, the agreement rate for the diagnosis of strict migraine (IHS categories 1.1 or 1.2) was 77.7% (kappa = 0.48), with 62.2% of the patients with this diagnosis (IHS categories 1.1 or 1.2) at Month 0 retaining the same diagnosis at Month 12. When diagnostic criteria were widened to include IHS category 1.7 (migrainous disorder), the agreement rate of the diagnosis was similar at 77.6% (kappa = 0.52), but 82% of the patients with this diagnosis (IHS categories 1.1 or 1.2 or 1.7) at Month 0 now retained the same diagnosis at Month 12. In conclusion, the one-year reproducibility of reporting of migraine headache symptoms is only moderate, varies between symptoms, and leads to instability in the formal assignment of a migraine headache diagnosis and to diagnostic drift between headache types. This finding is compatible with the continuum model of headache, where headache attacks can vary along a severity continuum from episodic tension-type headaches to full-blown migraine attacks.
Headache | 2005
F. Nachit-Ouinekh; Jean-François Dartigues; Virginie Chrysostome; Patrick Henry; Christophe Sourgen; Abdelkader El Hasnaoui
Objective.—To assess the evolution of headaches in a workplace cohort over a 10‐year period.
Cephalalgia | 2004
A. El Hasnaoui; Muriel Vray; P. Blin; F. Nachit-Ouinekh; F Boureau
We have recently developed an instrument to describe and categorize severity of migraine attacks from patient self-report, the MIGSEV questionnaire. We have now performed a large prospective survey using this tool to evaluate migraine severity in 2979 patients consulting for headache in France, included by 1164 general practitioners, 174 neurologists and 82 gynaecologists. The objective of the study was to determine the prevalence of severity grades in a large population who consults for migraine, to test the concordance between severity calculated from physician-derived and patient-derived data, and to test the relevance of the concept of severity as applied to diagnosis, other measures of the burden of migraine, and to health-related quality of life. Severe attacks were reported in around one-fifth of the sample. Physician- and patient-derived data provided concordant estimates of severity in 71% of cases, the discordant cases representing principally an underestimate by the physician of headache severity. Migraine severity was associated with frequent, long-lasting and treatment-resistant attacks, and with poor quality of life. The MIGSEV questionnaire is proposed as a simple measure of severity for the diagnosis and management of migraineurs, suitable for use both by physicians and patients.
Headache | 2009
Christelle Créac'h; Françoise Radat; Gérard Mick; Evelyne Guegan-Massardier; Pierric Giraud; Nathalie Guy; Nelly Fabre; F. Nachit-Ouinekh; Michel Lanteri-Minet
Background.— Whereas the clinical features of pure triptan overuse headache (TOH) are well known, there are insufficient data regarding the semiological pattern of headaches when triptan overuse is associated with other types of medication overuse.
Cephalalgia | 2007
Christian Lucas; Michel Lanteri-Minet; Hélène Massiou; F. Nachit-Ouinekh; André Pradalier; F Mercier; A. El Hasnaoui; Françoise Radat
The objective of this analysis was to identify variables associated with treatment response in subjects with migraine. Data were collected from a sample of 10 000 subjects. A battery of questionnaires assessing clinical and psychological variables was completed. Migraine diagnosis was attributed using an algorithm based on the IHS criteria and treatment response using the ANAES criteria. We identified 1534 subjects, of whom 1443 were treated. For 54.2%, at least one ANAES criterion for treatment response was unfulfilled. Non-response was associated with female gender, high HIT-6 impact scores and high HAD psychological distress scores. The strongest associations with non-response were identified for four psychological variables: elevated scores on the CSQ catastrophization subscale and the ‘Consequences’ and ‘Acceptance’ dimensions of the Brief COPE, and low scores on the ‘Positive Reinterpretation’ Brief COPE dimension. In conclusion, many individuals with migraine respond inadequately to treatment. Behavioural interventions aimed at modifying coping strategies may improve outcome.
Cephalalgia | 2008
J.-C. Cuvellier; Anne Donnet; Evelyne Guegan-Massardier; F. Nachit-Ouinekh; D. Parain; Louis Vallée
The aim of this study was to evaluate the concordance between clinical diagnosis and the International Classification of Headache Disorders, 2nd edn (ICHD-II) in children and adolescents with primary headaches. This 6-month prospective multicentre study of 486 patients (mean 9.8 ± 3.1 years; 52.6± girls) assessed the headache features through a structured questionnaire. In 398 patients with a single type of headache, headaches were bilateral (78.1±), frontal (62.4±), pulsatile (56.1±), with associated symptoms in 84.4±. The most frequently assigned diagnoses were migraine without aura (50.8±), probable migraine (14.1±), migraine with aura (11.1±) and frequent episodic tension-type headache (7.5±). For most of the diagnostic categories, the consistency of the investigators diagnosis with the ICHD-II criteria was good (K > 0.6 and ≤ 0.8) or excellent (K > 0.8). We conclude that migraine was predominant with regard to headache diagnoses repartition and that the ICHD-II seems usable in practice for evaluation of primary headache in French children and adolescents.